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1. Introduction 
Epidemiology is concerned with the study of 
the frequency of disease occurrence. Clinical epi- 
demiology is that part of epidemiology that deals 
with questions concerning clinical practice. Risk 
and prognosis are important concepts in clinical 
research and patient management. Risk of dis- 
ease can be viewed as the chance, or the proba- 
bility, that disease occurs. In order to know the 
probability of disease or death, one has to know 
the frequency of occurrence of disease. For the 
study of risk and prognosis the frequency of new 
disease events (incidence), and not the frequency 
of existing disease (prevalence) is of importance. 
This is because it is possible to estimate the 
probability of disease and thereby the risk of 
disease by estimating its incidence. The risk of 
disease can be measured in two ways: directly 
from the cumulative incidence, with or without 
use of the life table, and indirectly from the 
incidence rate. 
2. Risk estimation 
The most important measure of disease fre- 
quency is the cumulative incidence. The cumula- 
tive incidence is the number of new disease vents 
in a certain specified time period, divided by the 
total number of people without the disease (and 
therefore "at risk") at the beginning of that speci- 
fied period. Schematically the cumulative inci- 
dence (CI) in the period T o to T 1 can be given as 
follows: 
C I= 
new cases in period T 1 - T O 
number of people without disease at T O 
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The cumulative incidence is a proportion or frac- 
tion (e.g., a percentage). It is a probability that 
directly measures the disease risk, and it can vary 
from 0 to 1. In clinical medicine one preferably 
uses the cumulative incidence as a measure of 
disease frequency, but sometimes one is forced to 
use another measure: the incidence rate (IR). 
This also is a measure that uses the number of 
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new cases, but now divided by the number of 
person-years of follow-up: 
new cases 
IR= 
number of person-years of follow-up 
The number of person-years i the product of the 
number of persons and the period of observation 
of these persons. One hundred persons observed 
for 10 years amount to 1000 person-years. The 
incidence rate can vary from 0 to + infinity. 
The incidence rate is a more complicated mea- 
sure of frequency than the cumulative incidence. 
It has no simple interpretation, and it is not a 
proportion or percentage and it does not directly 
measure the probability or risk of disease. How- 
ever, it is possible to calculate the cumulative 
incidence from the incidence rate. With a reason- 
ably low incidence rate and a relatively short 
follow-up period the following rule of thumb may 
be used: 
f i a t  = IR X At. 
As an example, one can calculate the 5-year 
cumulative incidence of dementia for a 70-year- 
old Dutch man from the incidence rate of demen- 
tia in the age category 70-74 years (1.98/1000 
man-years). This gives an estimate of the risk to 
become demented within 5 years of CI 5 = 0.00198 
x 5 = 1%. A more extensive discussion with more 
general formulae to estimate the risk from an 
incidence rate can be found elsewhere [1]. 
3. Types of risk 
It is possible to distinguish between 3 types of 
risk: absolute risk, relative risk and attributable 
risk. 
The absolute risk is the probability of disease, 
complication or death. An absolute risk must be 
given for a specified time period. This can be a 
concretely defined time period, like the 10-year 
risk of a myocardial infarction in a 40-year-old 
man, but also a more abstract ime period, like 
the life-time risk of leukaemia, which denotes the 
probability that someone will suffer from 
leukaemia in his lifetime. In clinical medicine, 
absolute risks are used in various forms. The 5- 
or lO-year survival is a cumulative incidence. The 
lethality or case fatality is generally used as the 
risk of death in patients who suffer from a certain 
disease; it is a cumulative incidence of death. The 
term attack rate is often used for infectious dis- 
eases and it is a cumulative incidence over a short 
period of time. In clinical practice it is important 
to know the absolute risk as specifically as possi- 
ble. It is of little value to know the probability of 
a myocardial infarction in general. One would 
like to know that probability for men and women, 
for different ages, for persons with or without 
hypertension and with or without a positive fam- 
ily history for a myocardial infarction. In other 
words, one would like to know the risk of disease 
specified according to determinants of disease. 
These determinants are often called risk indica- 
tors because the disease risk varies with cate- 
gories of the determinants. A risk indicator with a 
causal relation with the disease is referred to as a 
risk factor. Age and sex are risk indicators for 
myocardial infarction, whereas blood pressure and 
serum lipids are risk factors; age is a risk indica- 
tor for lung cancer, and smoking habits a risk 
factor. 
A measure of risk that is often used is the 
relative risk. This measure has two forms: the risk 
ratio (RR) and the risk difference (RD). The term 
"risk ratio" is sometimes used as a synonym for 
the more general term "relative risk". It specifies 
the number of times that the absolute risk is 
higher in one category of the determinant (the 
index group) than in another category (the refer- 
ence group). As an example may serve that the 
risk ratio of smoking and lung cancer is about 10. 
This means that the absolute risk of lung cancer 
among smokers (R 1) is 10 times higher than the 
risk of lung cancer among non-smokers (R0). The 
risk ratio can be calculated by dividing the abso- 
lute risks of the index group (R 1) and the refer- 
ence group (R0): 
R1 
RR= 
R 0 9 
The risk ratio is a measure of risk with the lowest 
value of 0 and the highest value of + infinity. 
The null-value, that is the value in which the 
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absolute risks in the index and reference groups 
are the same, is one. 
The risk difference is the measure that gives 
the difference between two absolute risks. If the 
risk in the index group is given by R 1 and the risk 
in the reference group by R 0 then the risk differ- 
ence is given by: 
RD = R 1 - R 0 
This measure can be used to calculate how much 
the absolute risk of a patient is higher than that 
of a reference patient. The reciprocal of the risk 
difference, i.e. 1 /RD,  can be used to calculate 
the number of patients that have to be treated to 
prevent one "event" (complication, death). An 
example may be taken from a trial of patients 
with mild hypertension, conducted by the British 
Medical Research Council. In this MRC trial, 
patients with mild hypertension were treated with 
either an antihypertensive drug (beta-blocker or 
diuretic) or with a placebo. In comparing the 
efficacy of the antihypertensive treatment with 
the placebo treatment it was observed that the 
group on drug treatment ( he index group) had a 
10-year cumulative incidence of cerebrovascular 
stroke of 1.4% (R 1 = 0.014), compared to 2.6% 
(R 0 = 0.026) in the placebo group. The risk dif- 
ference was therefore 1.2%. This means that one 
has to treat for a period of 10 years 1/0.012 = 83 
patients with mild hypertension to prevent one 
cerebrovascular ccident. The same study showed 
that one has to treat 333 patients with mild 
hypertension for 10 years to prevent one myocar- 
dial infarction. 
A measure of risk which is often used in public 
health, and less in clinical practice, is the at- 
tributable risk (AR). This measure describes the 
proportion of sufferers from a disease that can be 
ascribed to one particular determinant or risk 
factor. The attributable risk can be calculated by 
dividing the risk difference by the absolute risk in 
the index group: 
R 1 - R 0 
AR 
R1 
This measure is also referred to as aetiological 
fraction, because it denotes what part of the risk 
(R 1) is the net effect of a certain risk of a certain 
factor (R 1 -R0) .  A more detailed discussion of 
the relation between relative and attributable risk 
can be found elsewhere [1]. 
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